CD8A and COVID-19: Studies carried out in acute and convalescent COVID-19 patients have indicated that the presence of T cell responses are associated with mild disease, implying that SARS-CoV-2-specific CD4+ helper T and CD8+ cytotoxic T cell responses may be crucial for control and resolution of primary SARS-CoV-2 infection [6–10].